{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:28:43Z","timestamp":1793460523972,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91638-0","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T17:27:54Z","timestamp":1741109274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["GOLPH3 promotes calcium oxalate-induced renal injury and fibrosis through Golgi stress-mediated apoptosis and inflammatory responses"],"prefix":"10.1038","volume":"15","author":[{"given":"Bao-feng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"9","key":"91638_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin, I. et al. Epidemiology of stone disease across the world. World J. Urol. 35(9), 1301\u20131320 (2017).","journal-title":"World J. Urol."},{"issue":"1","key":"91638_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/14756366.2016.1256884","volume":"32","author":"A Albert","year":"2017","unstructured":"Albert, A. et al. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease. J. Enzyme Inhib. Med. Chem. 32(1), 426\u2013433 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"91638_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.redox.2017.12.003","volume":"15","author":"M Patel","year":"2018","unstructured":"Patel, M. et al. Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox. Biol. 15, 207\u2013215 (2018).","journal-title":"Redox. Biol."},{"issue":"5","key":"91638_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00240-020-01202-w","volume":"48","author":"R Geraghty","year":"2020","unstructured":"Geraghty, R., Wood, K. & Sayer, J. A. Calcium oxalate crystal deposition in the kidney: Identification, causes and consequences. Urolithiasis 48(5), 377\u2013384 (2020).","journal-title":"Urolithiasis"},{"issue":"5","key":"91638_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/14728222.2019.1599359","volume":"23","author":"S Joshi","year":"2019","unstructured":"Joshi, S. & Khan, S. R. Opportunities for future therapeutic interventions for hyperoxaluria: Targeting oxidative stress. Expert. Opin. Ther. Targets 23(5), 379\u2013391 (2019).","journal-title":"Expert. Opin. Ther. Targets"},{"issue":"5","key":"91638_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00240-005-0492-4","volume":"33","author":"SR Khan","year":"2005","unstructured":"Khan, S. R. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol. Res. 33(5), 349\u2013357 (2005).","journal-title":"Urol. Res."},{"key":"91638_CR7","doi-asserted-by":"publisher","first-page":"110398","DOI":"10.1016\/j.intimp.2023.110398","volume":"121","author":"BF Song","year":"2023","unstructured":"Song, B. F. et al. Overexpression of sirtuin 1 attenuates calcium oxalate-induced kidney injury by promoting macrophage polarization. Int. Immunopharmacol. 121, 110398 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"91638_CR8","doi-asserted-by":"crossref","unstructured":"Bucurica, S. et al. Golgi apparatus target proteins in gastroenterological cancers: A comprehensive review of GOLPH3 and GOLGA proteins. Cells 12(14), 1\u20132 (2023).","DOI":"10.3390\/cells12141823"},{"key":"91638_CR9","doi-asserted-by":"publisher","first-page":"1197921","DOI":"10.3389\/fmolb.2023.1197921","volume":"10","author":"L Buzuk","year":"2023","unstructured":"Buzuk, L. & Hellerschmied, D. Ubiquitin-mediated degradation at the Golgi apparatus. Front. Mol. Biosci. 10, 1197921 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"91638_CR10","doi-asserted-by":"crossref","unstructured":"Mohan, A. G. et al. The Golgi apparatus: A Voyage through time, structure, function and implication in neurodegenerative disorders. Cells 12(15), 2\u20133 (2023).","DOI":"10.3390\/cells12151972"},{"issue":"4","key":"91638_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.14348\/molcells.2023.2152","volume":"46","author":"WK Kim","year":"2023","unstructured":"Kim, W. K. et al. Golgi stress response: New insights into the pathogenesis and therapeutic targets of human diseases. Mol. Cells 46(4), 191\u2013199 (2023).","journal-title":"Mol. Cells"},{"issue":"10","key":"91638_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s12272-022-01408-z","volume":"45","author":"W Choi","year":"2022","unstructured":"Choi, W., Kang, S. & Kim, J. New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases. Arch. Pharm. Res. 45(10), 671\u2013692 (2022).","journal-title":"Arch. Pharm. Res."},{"key":"91638_CR13","doi-asserted-by":"crossref","unstructured":"Liu, J. et al. The role of the Golgi apparatus in disease (Review). Int. J. Mol. Med. 47(4), 2 (2021).","DOI":"10.3892\/ijmm.2021.4871"},{"issue":"10","key":"91638_CR14","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41418-023-01220-2","volume":"30","author":"Y Kwon","year":"2023","unstructured":"Kwon, Y. et al. Identification of novel pathogenic roles of BLZF1\/ATF6 in tumorigenesis of gastrointestinal stromal tumor showing Golgi-localized mutant KIT. Cell. Death Differ. 30(10), 2309\u20132321 (2023).","journal-title":"Cell. Death Differ."},{"key":"91638_CR15","doi-asserted-by":"crossref","unstructured":"Vlad, D. B., Dumitrascu, D. I. & Dumitrascu, A. L. Golgi\u2019s role in the development of possible new therapies in cancer. Cells 12(11), 3 (2023).","DOI":"10.3390\/cells12111499"},{"key":"91638_CR16","doi-asserted-by":"crossref","unstructured":"Khine, M. N. & Sakurai, K. Golgi-targeting anticancer natural products. Cancers (Basel) 15(7), 1\u20136 (2023).","DOI":"10.3390\/cancers15072086"},{"key":"91638_CR17","doi-asserted-by":"crossref","unstructured":"Sechi, S. et al. Oncogenic roles of GOLPH3 in the physiopathology of cancer. Int. J. Mol. Sci. 21(3), 3\u20135 (2020).","DOI":"10.3390\/ijms21030933"},{"issue":"21","key":"91638_CR18","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.18632\/aging.204363","volume":"14","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation in vitro and in vivo. Aging (Albany NY) 14(21), 8745\u20138762 (2022).","journal-title":"Aging (Albany NY)"},{"key":"91638_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fnins.2015.00362","volume":"9","author":"MD Buschman","year":"2015","unstructured":"Buschman, M. D., Xing, M. & Field, S. J. The GOLPH3 pathway regulates Golgi shape and function and is activated by DNA damage. Front. Neurosci. 9, 362 (2015).","journal-title":"Front. Neurosci."},{"issue":"2 Pt A","key":"91638_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.tice.2016.06.008","volume":"49","author":"R Rizzo","year":"2017","unstructured":"Rizzo, R. et al. GOLPH3 and oncogenesis: What is the molecular link?. Tissue Cell. 49(2 Pt A), 170\u2013174 (2017).","journal-title":"Tissue Cell."},{"issue":"6","key":"91638_CR21","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.18632\/oncotarget.3051","volume":"6","author":"S Sechi","year":"2015","unstructured":"Sechi, S. et al. The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3. Oncotarget 6(6), 3493\u20133506 (2015).","journal-title":"Oncotarget"},{"key":"91638_CR22","doi-asserted-by":"publisher","first-page":"1265788","DOI":"10.3389\/fonc.2023.1265788","volume":"13","author":"P Kie\u0142b","year":"2023","unstructured":"Kie\u0142b, P. et al. Comparative analysis of GOLPH3 expression in lymph node-positive prostate cancer: Immunohistochemistry staining patterns and clinical significance. Front Oncol 13, 1265788 (2023).","journal-title":"Front Oncol"},{"key":"91638_CR23","doi-asserted-by":"publisher","first-page":"808152","DOI":"10.3389\/fmolb.2022.808152","volume":"9","author":"A Huang","year":"2022","unstructured":"Huang, A. et al. Golgi phosphoprotein 3 promotes colon cancer cell metastasis through STAT3 and Integrin \u03b13 pathways. Front. Mol. Biosci. 9, 808152 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"91638_CR24","doi-asserted-by":"publisher","first-page":"118294","DOI":"10.1016\/j.lfs.2020.118294","volume":"260","author":"T Yu","year":"2020","unstructured":"Yu, T. et al. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K\/AKT\/mTOR pathway. Life Sci. 260, 118294 (2020).","journal-title":"Life Sci."},{"issue":"2","key":"91638_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4103\/jcrt.jcrt_2348_21","volume":"18","author":"T Liu","year":"2022","unstructured":"Liu, T. et al. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance. J. Cancer Res. Ther. 18(2), 488\u2013495 (2022).","journal-title":"J. Cancer Res. Ther."},{"key":"91638_CR26","doi-asserted-by":"publisher","first-page":"2824984","DOI":"10.1155\/2020\/2824984","volume":"2020","author":"ZS Hong","year":"2020","unstructured":"Hong, Z. S. et al. Tenacissoside H induces apoptosis and inhibits migration of colon cancer cells by downregulating expression of GOLPH3 Gene. Evid. Based Complement Alternat. Med. 2020, 2824984 (2020).","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"7","key":"91638_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41419-023-05975-x","volume":"14","author":"T Dusabimana","year":"2023","unstructured":"Dusabimana, T. et al. GOLPH3 promotes endotoxemia-induced liver and kidney injury through Golgi stress-mediated apoptosis and inflammatory response. Cell Death Dis. 14(7), 458 (2023).","journal-title":"Cell Death Dis."},{"issue":"1","key":"91638_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.ajkd.2021.04.018","volume":"79","author":"S Yuan","year":"2022","unstructured":"Yuan, S. & Larsson, S. C. Coffee and caffeine consumption and risk of kidney stones: A Mendelian randomization study. Am. J. Kidney Dis. 79(1), 9-14.e1 (2022).","journal-title":"Am. J. Kidney Dis."},{"key":"91638_CR29","doi-asserted-by":"publisher","first-page":"774567","DOI":"10.3389\/fendo.2021.774567","volume":"12","author":"Z Qin","year":"2021","unstructured":"Qin, Z. et al. Higher triglyceride-glucose index is associated with increased likelihood of kidney stones. Front. Endocrinol. (Lausanne) 12, 774567 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"8","key":"91638_CR30","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1097\/JS9.0000000000001560","volume":"110","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Association between daily sitting time and kidney stones based on the National Health and Nutrition Examination Survey (NHANES) 2007\u20132016: A cross-sectional study. Int. J. Surg. 110(8), 4624\u20134632 (2024).","journal-title":"Int. J. Surg."},{"key":"91638_CR31","doi-asserted-by":"publisher","first-page":"1240171","DOI":"10.3389\/fendo.2023.1240171","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu, M. et al. Lifestyle factors, serum parameters, metabolic comorbidities, and the risk of kidney stones: A Mendelian randomization study. Front. Endocrinol. (Lausanne) 14, 1240171 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"91638_CR32","doi-asserted-by":"publisher","first-page":"1156097","DOI":"10.3389\/fpubh.2023.1156097","volume":"11","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. Association between alcohol consumption and kidney stones in American adults: 2007\u20132016 NHANES. Front. Public Health 11, 1156097 (2023).","journal-title":"Front. Public Health"},{"issue":"16","key":"91638_CR33","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJM199210153271607","volume":"327","author":"FL Coe","year":"1992","unstructured":"Coe, F. L., Parks, J. H. & Asplin, J. R. The pathogenesis and treatment of kidney stones. N. Engl. J. Med. 327(16), 1141\u20131152 (1992).","journal-title":"N. Engl. J. Med."},{"key":"91638_CR34","doi-asserted-by":"publisher","first-page":"114925","DOI":"10.1016\/j.biopha.2023.114925","volume":"164","author":"Z Ye","year":"2023","unstructured":"Ye, Z. et al. p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis. Biomed. Pharmacother 164, 114925 (2023).","journal-title":"Biomed. Pharmacother"},{"issue":"20","key":"91638_CR35","doi-asserted-by":"publisher","first-page":"e70180","DOI":"10.1111\/jcmm.70180","volume":"28","author":"Y Xu","year":"2024","unstructured":"Xu, Y. et al. Puerarin alleviates apoptosis and inflammation in kidney stone cells via the PI3K\/AKT pathway: Network pharmacology and experimental verification. J. Cell. Mol. Med. 28(20), e70180 (2024).","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"91638_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1538\/expanim.23-0113","volume":"73","author":"X Wang","year":"2024","unstructured":"Wang, X., Xie, L. & Liu, C. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation. Exp. Anim. 73(2), 211\u2013222 (2024).","journal-title":"Exp. Anim."},{"issue":"1","key":"91638_CR37","doi-asserted-by":"publisher","first-page":"2416825","DOI":"10.1080\/13510002.2024.2416825","volume":"29","author":"X Su","year":"2024","unstructured":"Su, X. et al. Selenium participates in the formation of kidney stones by alleviating endoplasmic reticulum stress and apoptosis of renal tubular epithelial cells. Redox Rep. 29(1), 2416825 (2024).","journal-title":"Redox Rep."},{"issue":"12","key":"91638_CR38","first-page":"963","volume":"1","author":"CC Wu","year":"2000","unstructured":"Wu, C. C. et al. GMx33: A novel family of trans-Golgi proteins identified by proteomics. Traffic 1(12), 963\u2013975 (2000).","journal-title":"Traffic"},{"issue":"3","key":"91638_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbrc.2013.03.003","volume":"433","author":"X Zhou","year":"2013","unstructured":"Zhou, X. et al. GOLPH3 regulates the migration and invasion of glioma cells though RhoA. Biochem. Biophys. Res. Commun. 433(3), 338\u2013344 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"91638_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/mc.22197","volume":"54","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro. Mol. Carcinog. 54(11), 1252\u20131263 (2015).","journal-title":"Mol. Carcinog."},{"issue":"15","key":"91638_CR41","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1158\/1078-0432.CCR-11-3156","volume":"18","author":"Z Zeng","year":"2012","unstructured":"Zeng, Z. et al. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin. Cancer Res. 18(15), 4059\u20134069 (2012).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"91638_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jcb.21475","volume":"102","author":"KM Quesnelle","year":"2007","unstructured":"Quesnelle, K. M., Boehm, A. L. & Grandis, J. R. STAT-mediated EGFR signaling in cancer. J. Cell. Biochem. 102(2), 311\u2013319 (2007).","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"91638_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11060-018-2884-7","volume":"139","author":"S Wu","year":"2018","unstructured":"Wu, S. et al. GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation. J. Neurooncol. 139(2), 269\u2013279 (2018).","journal-title":"J. Neurooncol."},{"issue":"5","key":"91638_CR44","first-page":"722","volume":"33","author":"J Jia","year":"2023","unstructured":"Jia, J. et al. GOLPH3 promotes vasculogenic mimicry via the epithelial mesenchymal transition in glioblastoma cells. Turk. Neurosurg. 33(5), 722\u2013730 (2023).","journal-title":"Turk. Neurosurg."},{"issue":"2","key":"91638_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1194\/jlr.R088328","volume":"60","author":"RS Kuna","year":"2019","unstructured":"Kuna, R. S. & Field, S. J. GOLPH3: A Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer. J. Lipid Res. 60(2), 269\u2013275 (2019).","journal-title":"J. Lipid Res."},{"issue":"4","key":"91638_CR46","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1158\/0008-5472.CAN-14-3081","volume":"75","author":"MD Buschman","year":"2015","unstructured":"Buschman, M. D., Rahajeng, J. & Field, S. J. GOLPH3 links the Golgi, DNA damage, and cancer. Cancer Res. 75(4), 624\u2013627 (2015).","journal-title":"Cancer Res."},{"issue":"11","key":"91638_CR47","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41419-022-05438-9","volume":"13","author":"A Frappaolo","year":"2022","unstructured":"Frappaolo, A. et al. GOLPH3 protein controls organ growth by interacting with TOR signaling proteins in Drosophila. Cell Death Dis. 13(11), 1003 (2022).","journal-title":"Cell Death Dis."},{"issue":"1\u20132","key":"91638_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijpharm.2017.03.092","volume":"524","author":"F Mottaghitalab","year":"2017","unstructured":"Mottaghitalab, F. et al. Prospects of siRNA applications in regenerative medicine. Int. J. Pharm. 524(1\u20132), 312\u2013329 (2017).","journal-title":"Int. J. Pharm."},{"issue":"30","key":"91638_CR49","doi-asserted-by":"publisher","first-page":"e2311690","DOI":"10.1002\/smll.202311690","volume":"20","author":"C Li","year":"2024","unstructured":"Li, C. et al. Cholesterol-modified DNA nanostructures serve as effective non-viral carriers for delivering siRNA to the kidneys to prevent acute kidney injury. Small 20(30), e2311690 (2024).","journal-title":"Small"},{"key":"91638_CR50","doi-asserted-by":"publisher","first-page":"683247","DOI":"10.3389\/fbioe.2021.683247","volume":"9","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. Targeted drug delivery systems for kidney diseases. Front. Bioeng. Biotechnol. 9, 683247 (2021).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"36","key":"91638_CR51","first-page":"e2303597","volume":"10","author":"H Zhou","year":"2023","unstructured":"Zhou, H. et al. Stimuli-responsive nanotechnology for RNA delivery. Adv. Sci. (Weinh.) 10(36), e2303597 (2023).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"91638_CR52","doi-asserted-by":"publisher","first-page":"114417","DOI":"10.1016\/j.addr.2022.114417","volume":"188","author":"T Nakamura","year":"2022","unstructured":"Nakamura, T. et al. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines. Adv. Drug. Deliv. Rev. 188, 114417 (2022).","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"8","key":"91638_CR53","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00018-013-1502-2","volume":"71","author":"LC Gomes-da-Silva","year":"2014","unstructured":"Gomes-da-Silva, L. C., Sim\u00f5es, S. & Moreira, J. N. Challenging the future of siRNA therapeutics against cancer: The crucial role of nanotechnology. Cell. Mol. Life Sci. 71(8), 1417\u20131438 (2014).","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"91638_CR54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7(8), 606\u2013619 (2006).","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"91638_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","volume":"7","author":"DR Alessi","year":"1997","unstructured":"Alessi, D. R. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7(4), 261\u2013269 (1997).","journal-title":"Curr Biol"},{"issue":"3","key":"91638_CR56","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB signaling: Navigating the network. Cell 169(3), 381\u2013405 (2017).","journal-title":"Cell"},{"key":"91638_CR57","doi-asserted-by":"publisher","first-page":"112085","DOI":"10.1016\/j.exger.2023.112085","volume":"172","author":"J Peng","year":"2023","unstructured":"Peng, J. et al. Aspirin alleviates pulmonary fibrosis through PI3K\/AKT\/mTOR-mediated autophagy pathway. Exp. Gerontol. 172, 112085 (2023).","journal-title":"Exp. Gerontol."},{"key":"91638_CR58","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fphar.2020.00128","volume":"11","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Dexmedetomidine protects against lipopolysaccharide-induced acute kidney injury by enhancing autophagy through inhibition of the PI3K\/AKT\/mTOR pathway. Front. Pharmacol. 11, 128 (2020).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91638-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:20:12Z","timestamp":1741112412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91638-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91638"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91638-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7640"}}